Thermo Fisher to acquire Solventum's purification and filtration business for $4.1B

THERMO FISHER SCIENTIFIC INC.

Deal value approximately $4.1 billion in cash.
Expected to close by end of 2025, subject to regulatory approvals and customary conditions.
Acquisition expands Thermo Fisher's purification and filtration capabilities within life sciences.
Solventum is the seller; transaction structured as asset purchase of the business.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.